Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Elizabeth Anderson maintains an Outperform rating on Privia Health Group (PRVA) but lowers the price target from $26 to $25.

February 28, 2024 | 5:23 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Evercore ISI Group maintains an Outperform rating on Privia Health Group but lowers the price target from $26 to $25.
The adjustment in price target by Evercore ISI Group, while maintaining an Outperform rating, suggests a continued positive outlook on PRVA but with slightly moderated expectations. This could lead to a neutral short-term impact on the stock as the market digests the slight reduction in the price target against the backdrop of sustained analyst confidence.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90